Ameriprise’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.14M | Buy |
443,749
+313,160
| +240% | +$3.63M | ﹤0.01% | 2337 |
|
2025
Q1 | $1.14M | Buy |
+130,589
| New | +$1.14M | ﹤0.01% | 3132 |
|
2024
Q4 | – | Sell |
-77,371
| Closed | -$1.75M | – | 4130 |
|
2024
Q3 | $1.75M | Buy |
77,371
+16,810
| +28% | +$380K | ﹤0.01% | 2971 |
|
2024
Q2 | $1.18M | Sell |
60,561
-405,793
| -87% | -$7.89M | ﹤0.01% | 3093 |
|
2024
Q1 | $17.5M | Sell |
466,354
-48,987
| -10% | -$1.84M | ﹤0.01% | 1388 |
|
2023
Q4 | $28.8M | Buy |
515,341
+500,802
| +3,445% | +$28M | 0.01% | 1063 |
|
2023
Q3 | $600K | Sell |
14,539
-15,845
| -52% | -$654K | ﹤0.01% | 3334 |
|
2023
Q2 | $1.7M | Sell |
30,384
-22,736
| -43% | -$1.27M | ﹤0.01% | 2957 |
|
2023
Q1 | $2.96M | Sell |
53,120
-5,704
| -10% | -$318K | ﹤0.01% | 2647 |
|
2022
Q4 | $2.14M | Buy |
58,824
+6,057
| +11% | +$221K | ﹤0.01% | 2776 |
|
2022
Q3 | $1.5M | Sell |
52,767
-4,747
| -8% | -$135K | ﹤0.01% | 2911 |
|
2022
Q2 | $2.6M | Sell |
57,514
-1,578,382
| -96% | -$71.5M | ﹤0.01% | 2708 |
|
2022
Q1 | $124M | Buy |
1,635,896
+40,627
| +3% | +$3.09M | 0.04% | 451 |
|
2021
Q4 | $238M | Buy |
1,595,269
+520,671
| +48% | +$77.6M | 0.07% | 309 |
|
2021
Q3 | $156M | Sell |
1,074,598
-255,124
| -19% | -$37.1M | 0.05% | 392 |
|
2021
Q2 | $260M | Sell |
1,329,722
-79,485
| -6% | -$15.6M | 0.08% | 260 |
|
2021
Q1 | $255M | Buy |
1,409,207
+37,573
| +3% | +$6.8M | 0.08% | 239 |
|
2020
Q4 | $194M | Buy |
1,371,634
+606,538
| +79% | +$85.9M | 0.07% | 294 |
|
2020
Q3 | $95.4M | Buy |
765,096
+224,219
| +41% | +$28M | 0.04% | 434 |
|
2020
Q2 | $48.3M | Buy |
540,877
+347,974
| +180% | +$31.1M | 0.02% | 636 |
|
2020
Q1 | $12M | Buy |
192,903
+176,093
| +1,048% | +$11M | 0.01% | 1257 |
|
2019
Q4 | $1.28M | Buy |
16,810
+6,086
| +57% | +$464K | ﹤0.01% | 2951 |
|
2019
Q3 | $540K | Buy |
+10,724
| New | +$540K | ﹤0.01% | 3272 |
|